Stay updated on Safety of Selonsertib, Firsocostat, & Cilofexor in NASH Clinical Trial
Sign up to get notified when there's something new on the Safety of Selonsertib, Firsocostat, & Cilofexor in NASH Clinical Trial page.

Latest updates to the Safety of Selonsertib, Firsocostat, & Cilofexor in NASH Clinical Trial page
- Check6 days agoChange DetectedThe revision tag on the page was updated from v3.5.4 to v3.5.5, indicating a newer version of the page's documentation.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe page's revision label changed from v3.5.3 to v3.5.4, indicating a minor version update to the page's documentation/history.SummaryDifference0.0%

- Check49 days agoChange DetectedUpdates the ClinicalTrials.gov page footer from **Revision: v3.5.2** to **Revision: v3.5.3**.SummaryDifference0.0%

- Check56 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check70 days agoChange Detected- Removed the topic 'Non-alcoholic fatty liver disease' and the related topic 'MedlinePlus Genetics' from the page.SummaryDifference0.1%

- Check85 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0 in the page header.SummaryDifference0.0%

Stay in the know with updates to Safety of Selonsertib, Firsocostat, & Cilofexor in NASH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Selonsertib, Firsocostat, & Cilofexor in NASH Clinical Trial page.